- Home
- ARMP vs DVLT Comparison
ARMP vs DVLT Comparison
Compare ARMP & DVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- DVLT
- Stock Information
- Founded
- ARMP N/A
- DVLT 2010
- Country
- ARMP United States
- DVLT United States
- Employees
- ARMP N/A
- DVLT N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- DVLT
- Sector
- ARMP Health Care
- DVLT
- Exchange
- ARMP Nasdaq
- DVLT NYSE
- Market Cap
- ARMP 52.1M
- DVLT 55.7M
- IPO Year
- ARMP N/A
- DVLT N/A
- Fundamental
- Price
- ARMP $2.22
- DVLT $0.71
- Analyst Decision
- ARMP Strong Buy
- DVLT Strong Buy
- Analyst Count
- ARMP 1
- DVLT 1
- Target Price
- ARMP $9.00
- DVLT $3.00
- AVG Volume (30 Days)
- ARMP 18.4K
- DVLT 2.1M
- Earning Date
- ARMP 08-12-2025
- DVLT 08-13-2025
- Dividend Yield
- ARMP N/A
- DVLT N/A
- EPS Growth
- ARMP N/A
- DVLT N/A
- EPS
- ARMP N/A
- DVLT N/A
- Revenue
- ARMP $4,699,000.00
- DVLT $3,048,000.00
- Revenue This Year
- ARMP $8.43
- DVLT $434.03
- Revenue Next Year
- ARMP N/A
- DVLT $221.43
- P/E Ratio
- ARMP N/A
- DVLT N/A
- Revenue Growth
- ARMP 14.24
- DVLT 63.08
- 52 Week Low
- ARMP $0.90
- DVLT $0.60
- 52 Week High
- ARMP $3.42
- DVLT $3.25
- Technical
- Relative Strength Index (RSI)
- ARMP 63.56
- DVLT N/A
- Support Level
- ARMP $1.93
- DVLT N/A
- Resistance Level
- ARMP $2.24
- DVLT N/A
- Average True Range (ATR)
- ARMP 0.16
- DVLT 0.00
- MACD
- ARMP 0.03
- DVLT 0.00
- Stochastic Oscillator
- ARMP 104.55
- DVLT 0.00
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About DVLT DATAVAULT AI INC
Datavault AI Inc is a data technology and licensing company that enables clients and strategic partners to monetize their Blockchain Data and AI Web 3.0 assets via tokenization, data ownership and digital twins offering two solutions: Data Science licenses High-Performance Computing (HPC) software applications and Web 3.0 data management serving the biotech, energy, education, fintech, real estate, and healthcare industries, among others. Acoustic Science licenses spatial and multichannel HD sound transmission, including proprietary brands ADIO, WiSA and Sumerian, to customers in sports & entertainment, events & venues, restaurants, automotive, finance, and other industries.